156 related articles for article (PubMed ID: 32868633)
1. Factors Associated With Voriconazole Concentration in Pediatric Patients.
Kang S; Yee J; Kim JY; Han HW; Kang SO; Lee KE; Gwak HS
Ther Drug Monit; 2020 Dec; 42(6):866-871. PubMed ID: 32868633
[TBL] [Abstract][Full Text] [Related]
2. Inflammation is associated with voriconazole trough concentrations.
van Wanrooy MJ; Span LF; Rodgers MG; van den Heuvel ER; Uges DR; van der Werf TS; Kosterink JG; Alffenaar JW
Antimicrob Agents Chemother; 2014 Dec; 58(12):7098-101. PubMed ID: 25223994
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Drug Monitoring of Voriconazole in Children from a Tertiary Care Center in China.
Hu L; Dai TT; Zou L; Li TM; Ding XS; Yin T
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30150475
[TBL] [Abstract][Full Text] [Related]
4. Voriconazole concentration is inversely correlated with corticosteroid usage in immunocompromised patients.
Imataki O; Yamaguchi K; Uemura M; Fukuoka N
Transpl Infect Dis; 2018 Aug; 20(4):e12886. PubMed ID: 29570914
[TBL] [Abstract][Full Text] [Related]
5. Influence of switching from intravenous to oral administration on serum voriconazole concentration.
Harada S; Niwa T; Hoshino Y; Fujibayashi A; Suzuki A
J Clin Pharm Ther; 2021 Jun; 46(3):780-785. PubMed ID: 33393135
[TBL] [Abstract][Full Text] [Related]
6. Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis.
Jin H; Wang T; Falcione BA; Olsen KM; Chen K; Tang H; Hui J; Zhai S
J Antimicrob Chemother; 2016 Jul; 71(7):1772-85. PubMed ID: 26968880
[TBL] [Abstract][Full Text] [Related]
7. Oral administration and younger age decrease plasma concentrations of voriconazole in pediatric patients.
Kato K; Nagao M; Yamamoto M; Matsumura Y; Takakura S; Fukuda K; Ichiyama S
J Infect Chemother; 2016 Jan; 22(1):27-31. PubMed ID: 26538245
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of voriconazole helps to decrease the percentage of patients with off-target trough serum levels.
Guinea J; Escribano P; Marcos-Zambrano LJ; Peláez T; Kestler M; Muñoz P; Vena A; López-Fabal F; Bouza E
Med Mycol; 2016 May; 54(4):353-60. PubMed ID: 26739190
[TBL] [Abstract][Full Text] [Related]
9. Impact of Inflammation on Intra-individual Variation in Trough Voriconazole Concentration in Patients with Hematological Malignancies.
Maeda Y; Tanaka R; Tatsuta R; Takano K; Hashimoto T; Ogata M; Hiramatsu K; Itoh H
Biol Pharm Bull; 2022; 45(8):1084-1090. PubMed ID: 35908890
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
Li H; Li M; Yan J; Gao L; Zhou L; Wang Y; Li Q; Wang J; Chen T; Wang T; Zheng J; Qiang W; Zhang Y; Shi Q
Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):495-504. PubMed ID: 32639669
[TBL] [Abstract][Full Text] [Related]
11. Pediatric Clinical Pharmacology of Voriconazole: Role of Pharmacokinetic/Pharmacodynamic Modeling in Pharmacotherapy.
Kadam RS; Van Den Anker JN
Clin Pharmacokinet; 2016 Sep; 55(9):1031-43. PubMed ID: 26979736
[TBL] [Abstract][Full Text] [Related]
12. Observational Study of Associations between Voriconazole Therapeutic Drug Monitoring, Toxicity, and Outcome in Liver Transplant Patients.
Hashemizadeh Z; Badiee P; Malekhoseini SA; Raeisi Shahraki H; Geramizadeh B; Montaseri H
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923870
[TBL] [Abstract][Full Text] [Related]
13. Highly variable plasma concentrations of voriconazole in pediatric hematopoietic stem cell transplantation patients.
Bartelink IH; Wolfs T; Jonker M; de Waal M; Egberts TC; Ververs TT; Boelens JJ; Bierings M
Antimicrob Agents Chemother; 2013 Jan; 57(1):235-40. PubMed ID: 23114771
[TBL] [Abstract][Full Text] [Related]
14. A Prospective Study on the Usefulness of Initial Voriconazole Dose Adjustment Based on CYP2C19 Gene Polymorphism Analysis.
Tanaka R; Fujioka T; Suzuki Y; Iwao M; Itoh H
Chemotherapy; 2020; 65(3-4):59-64. PubMed ID: 32877905
[TBL] [Abstract][Full Text] [Related]
15. The Influence of Proinflammatory Cytokines on Voriconazole Trough Concentration in Patients With Different Forms of Hematologic Disorders.
Mafuru M; Wu S; He S; Lu X; Huang J; Jiang H
J Clin Pharmacol; 2019 Oct; 59(10):1340-1350. PubMed ID: 30997931
[TBL] [Abstract][Full Text] [Related]
16. Interpersonal Factors in the Pharmacokinetics and Pharmacodynamics of Voriconazole: Are CYP2C19 Genotypes Enough for Us to Make a Clinical Decision?
Zhong X; Tong X; Ju Y; Du X; Li Y
Curr Drug Metab; 2018; 19(14):1152-1158. PubMed ID: 29361899
[TBL] [Abstract][Full Text] [Related]
17. Variability of voriconazole concentrations in patients with hematopoietic stem cell transplantation and hematological malignancies: influence of loading dose, procalcitonin, and pregnane X receptor polymorphisms.
Zeng G; Wang L; Shi L; Li H; Zhu M; Luo J; Zhang Z
Eur J Clin Pharmacol; 2020 Apr; 76(4):515-523. PubMed ID: 31932875
[TBL] [Abstract][Full Text] [Related]
18. Voriconazole treatment in adults and children with hematological diseases: can it be used without measurement of plasma concentration?
Girmenia C; Annino L; Bertaina A; Mariotti B; Caselli D; Fanci R; Barberi W; Marchesi F; Carotti A; Ferrari A; Cerchiara E; Cupelli L; Arcioni F; Ribersani M; Proia A; Cartoni C; Girardi K; Venditti A; Cassetta MI; Fallani S; Novelli A
Med Mycol; 2018 Apr; 56(3):263-278. PubMed ID: 28992093
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring and safety of voriconazole in elderly patients.
Cheng L; Xiang R; Liu F; Li Y; Chen H; Yao P; Sun F; Xia P
Int Immunopharmacol; 2020 Jan; 78():106078. PubMed ID: 31830620
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Drug Monitoring of Voriconazole in Critically Ill Pediatric Patients: A Single-Center Retrospective Study.
Taher KW; Almofada R; Alomair S; Albassam AA; Alsultan A
Paediatr Drugs; 2024 Mar; 26(2):197-203. PubMed ID: 38228969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]